Patients with IBD could take drug holidays for COVID-19 protection
The GESA has published recommendations on managing IBD patients and colonoscopy deferral during the pandemic
Patients with IBD who are stable on immunosuppressants or biologic therapy could take a drug holiday to minimise their COVID-19 risk, it is now recommended.